Coronado Industries Featured in EQUITIES Magazine; Gains Worldwide Exposure.FOUNTAIN HILLS, Ariz. -- Coronado Industries (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : CNDO CNDO Complete Neglect of Differential Overlap CNDO Congenital Nasolacrimal Duct Obstruction ), with its patented glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). treatment "PNT PNT Point PNT Paint (MacPaint graphic file format) PNT Patient PNT Pentagon (Washington, DC; US DoD) PNT Positioning, Navigation and Timing PNT Prime Number Theorem PNT Phenytoin ," will be the subject of a two-page feature article in this month's issue of EQUITIES Magazine. This issue will be distributed internationally and also available in newsstands. G. Richard Smith, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Coronado Industries, said, "We couldn't be happier with the international exposure that we are being given. EQUITIES is the premier magazine in their industry, and we are very excited to get our story out to the investment community." Ophthalmic International (a subsidiary of Coronado Industries) is focused on the development and commercialization of its patented procedure as a cost-effective alternative for the treatment of the most common types of glaucoma, which are open angle and pigmentary as well as for the treatment of ocular hypertension. For more information, please visit our Web sites at www.ophthalmicinternational.com or www.coronadoindustries.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion